Journal of Materials Chemistry B · 2018 · 10 citations · 34 references
PharmacyBiotechnologyPharmaceuticsDrug DeliveryGene DeliveryStimuli-responsive Drug DeliveryCancer NanomedicineDrug EncapsulationGene Delivery VectorsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineChitosanChitosan NanocarriersDrug Delivery NanocarriersGene Delivery NanocarriersGene Delivery NanomaterialsNanocarrier BiocompatibilityNanoparticle DeliveryNanoparticle Delivery Vectors
Stimuli-responsive delivery systems show great promise in meeting the requirements of several delivery stages to achieve satisfactory gene transfection. This report describes a novel stimuli-responsive nanocarrier consisting of a dual stimuli-responsive chitosan (SCS) core and a polyethyleneimine (PEI) and polyethylene glycol (PEG) corona. The SCS core was constructed by cross-linking bio-safe chitosan saccharide via pH-sensitive hydrazone bonds and redox-sensitive disulfide bonds, which conferred the nanocarrier with a dual stimuli-responsive property. PEG and low-molecular-weight PEI were further immobilized on the core to endow the synthesized SCS-g-PEI-g-PEG with improved gene condensation, prolonged circulation and enhanced lysosome escape. In vitro and in vivo Birc5-shRNA delivery results revealed that significantly enhanced gene expression and tumor inhibition were achieved by SCS-g-PEI-g-PEG, compared with the non-stimuli-responsive counterpart CS-g-PEI-g-PEG. Moreover, the SCS-g-PEI-g-PEG nanocarrier was biocompatible as shown in both in vitro and in vivo toxicity evaluations. This study may provide a promising strategy for constructing an efficient and bio-safe delivery system for gene therapy.
34
Hydrolytic Stability of Hydrazones and Oximes
Jeet Kalia, Ronald T. Raines · Angewandte Chemie International Edition · 2008 · 879 citations · Full text
First oncolytic virus approved for melanoma immunotherapy
Jonathan Pol, Guido Kroemer, Lorenzo Galluzzi · OncoImmunology · 2015 · 375 citations · Full text
Medicine, Immunology, Oncology +17
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Daniel R. Scoles, Pratap Meera, Matthew Schneider et al. · Nature · 2017 · 330 citations
Chitosan-graft-polyethylenimine as a gene carrier
Hu‐Lin Jiang, You-Kyoung Kim, Rohidas Arote et al. · Journal of Controlled Release · 2006 · 290 citations